Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and mangostin

9,10-dimethyl-1,2-benzanthracene has been researched along with mangostin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, W; Liu, Z; Ma, H; Wang, F; Xu, X; Zhang, X1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and mangostin

ArticleYear
α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 92

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinogens; Dose-Response Relationship, Drug; Female; Inflammation; Mice; Mice, Inbred ICR; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Random Allocation; Signal Transduction; Skin Neoplasms; TOR Serine-Threonine Kinases; Xanthones

2017